At Chula4DR, we focus on discovery of novel small molecule therapeutics starting from ‘Hits’ or “Leads”, advancing optimal compounds to pre-IND stage.
• Hepatitis B virus (HBV)
• Immuno-oncology
• Central nervous system (CNS)